American Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
American Regent, Inc. is recalling Cyanocobalamin injections because they contain particulate matter, including hair, glass, and paraformaldehyde.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class II recall. The presence of glass and paraformaldehyde in an injectable drug represents a significant injury risk, meeting the criteria for a Severe rating.
Plain-English summary
American Regent, Inc. is recalling Cyanocobalamin injection USP, 1,000 mcg/mL, packaged in 1 mL and 25x1 mL multi-dose vials. The recall affects 235,350 vials distributed nationwide within the U.S. The specific lots involved are 24297 (Exp. Date 8/31/2026) and 24364 (Exp. Date 10/31/2026).
The recall was initiated because the product is contaminated with particulate matter identified as hair, glass, and/or paraformaldehyde. This contamination poses a risk to patients receiving the medication via intramuscular or subcutaneous injection.
Healthcare providers and patients should stop using the affected vials and contact American Regent, Inc. for further instructions or returns.
The recalled product
- Product
- CYANOCOBALAMIN (CYANOCOBALAMIN)
- Brand
- CYANOCOBALAMIN
- Manufacturer
- American Regent, Inc.
- Category
- Drug — Injectable Vitamin
- Affected units
- 235,350
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 24297
- Exp. Date 8/31/2026
- 24364
- Exp. Date: 10/31/2026
UPCs (2)
- 0305170031251
- 0305170032258
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CYANOCOBALAMIN
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- ModerateCyanocobalamin Injection Recalled for Subpotent Drug - Out of Specification Assay
FDA (Drugs) · 2022-04-20
- ModerateCardinal Health Recalls Cyanocobalamin Injection Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- SevereFresenius Kabi Recalls Cyanocobalamin Vials Due to Sterility Concerns
FDA (Drugs) · 2014-12-17
Same manufacturer · American Regent, Inc.
See all →- SevereFDA Recalls Nicardipine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Multrys Trace Elements Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- CriticalAmerican Regent Recalls Papaverine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Atropine Sulfate Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Nitroglycerin Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereAmerican Regent Recalls Tralement Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26